Delivery Order SPE2DB22D9353-SPE2DB23FX2HU
- Not listed
- This federal contract award, valued at $25,564.66, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Alecensa 150 mg capsules, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This federal contract award is for the delivery of Alecensa 150 mg capsules to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $12,474.29 and a completion date of August 13, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $12,474.29 firm fixed-price delivery order contract is for the supply of Alecensa 150 mg capsules. The award is part of a larger indefinite delivery vehicle (IDV) contract, valued at up to $4,999,999, that DMS Pharmaceutical Group Inc. holds with the DLA under the SPE2DB program. This single-award IDV enables...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,948.60 firm fixed-price delivery order contract is for the supply of the branded pharmaceutical product Alecensa 150 mg capsule, with an ultimate completion date of July 2, 2024. The contract is part of DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA,...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,474.29, is for the supply of 4,564,014,996 units of the medication Alecensa 150 mg capsules. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,047.88, is for the delivery of the pharmaceutical product Alecensa 150 mg capsules. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
- This firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $62,371.45, is for the delivery of the pharmaceutical product Alecensa 150 mg capsules. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the DLA to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $38,346.96, is a firm fixed-price delivery order for the supply of Alecensa 150 mg capsules. The contract has a completion date of March 28, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,897.20 contract is for the delivery of Alecensa 150 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical...
- The federal contract award SPE2DX15D9168 was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $96,383.04 firm fixed-price delivery order is for the supply of the prescription drug Alecensa 150 mg capsules, with a completion date of February 10, 2023. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB23FX2HUDelivery Order
This federal contract award, valued at $24,095.76, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Alecensa 150mg capsules, with a performance period ending on September 14, 2023. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award vehicle, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The current award is issued under this larger IDC contract, and does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.1k | 8/23/23 |